Rinvoq Interactions
There are 600 drugs known to interact with Rinvoq (upadacitinib), along with 9 disease interactions, and 2 alcohol/food interactions. Of the total drug interactions, 380 are major, 210 are moderate, and 10 are minor.
- View all 600 medications that may interact with Rinvoq
- View Rinvoq alcohol/food interactions (2)
- View Rinvoq disease interactions (9)
Most frequently checked interactions
View interaction reports for Rinvoq (upadacitinib) and the medicines listed below.
- amlodipine
- atorvastatin
- cyclobenzaprine
- Cymbalta (duloxetine)
- doxycycline
- duloxetine
- famotidine
- folic acid
- gabapentin
- Humira (adalimumab)
- hydroxychloroquine
- hydroxyzine
- ibuprofen
- levothyroxine
- lisinopril
- losartan
- melatonin
- meloxicam
- metformin
- methotrexate
- omeprazole
- pantoprazole
- prednisone
- rosuvastatin
- sulfasalazine
- tramadol
- trazodone
- Vitamin B12 (cyanocobalamin)
- Vitamin D3 (cholecalciferol)
- Zyrtec (cetirizine)
Rinvoq alcohol/food interactions
There are 2 alcohol/food interactions with Rinvoq (upadacitinib).
Rinvoq disease interactions
There are 9 disease interactions with Rinvoq (upadacitinib) which include:
- cardiovascular risk
- malignancy
- thrombosis
- infections
- cytopenias
- gastrointestinal perforation
- hepatic impairment
- hyperlipidemia
- vaccination
Report options
More about Rinvoq (upadacitinib)
- Rinvoq consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (227)
- Drug images
- Latest FDA alerts (1)
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: antirheumatics
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Xeljanz
Xeljanz (tofacitinib) is an oral Janus kinase (JAK) inhibitor that may be used alone or with other ...
Entyvio
Entyvio (vedolizumab) is used to treat ulcerative colitis (UC) and Crohn's disease, reducing ...
Otezla
Otezla (apremilast) is used to treat plaque psoriasis, psoriatic arthritis, and oral ulcers ...
Skyrizi
Skyrizi (risankizumab) is used to treat plaque psoriasis, psoriatic arthritis, ulcerative colitis ...
Dupixent
Dupixent is used to treat eczema, eosinophilic or oral-corticosteroid-dependent asthma, chronic ...
Stelara
Stelara (ustekinumab) is used to treat Crohn's disease, ulcerative colitis, plaque psoriasis, and ...
Taltz
Taltz (ixekizumab) is used to treat plaque psoriasis, psoriatic arthritis, and ankylosing ...
Aspirin
Aspirin is used to treat mild to moderate pain and to reduce fever or inflammation. Learn about ...
Prednisone
Prednisone is used to treat allergic disorders, ulcerative colitis, psoriasis and arthritis. Learn ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
